The journal follows the flowcharts and guidelines of the Committee on Publication Ethics (COPE) in confronting any ethical misbehavior. The Journal also follows the guidelines mentioned in the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals issued by the International Committee of Medical Journal Editors (ICMJE) (ICMJE | Recommendations)
Submitted articles are primarily evaluated for any methodological flaws, format, and their compliance with the Journal’s instructions.
Through a double-blind review, the articles will be reviewed by at least two external (peer) reviewers. Their comments will be passed to the authors and their responses to the comments along with the reviewers’ comments will then be evaluated by the Editor-in-Chief.
The final review process will be discussed in regular editorial board sessions and on the basis of the comments, and the Journal’s standards, the Editor-in-Chief will decide which articles should be published.
It should be noted that articles submitted by the staff and editors of the CBJ will also be subjected to peer review, and the authors will be completely blind to the evaluation process of their article until a final decision has been made.
Studies that involve human beings (or animals) must adhere to the principles of the Declaration of Helsinki.
All patients and participants in a study should be thoroughly informed about the aims of the study and any possible side effects of the drugs and interventions. Written informed consent from the participants or their legal guardians is necessary for any such studies. The Journal reserves the right to request the related documents. Articles that require informed consent should contain related statement in the “Method” section.
According to the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals, released by the ICMJE, an “Author” is generally considered to be someone who simultaneously meets the following conditions 1, 2, 3, and 4. (http://www.icmje.org/icmje-recommendations.pdf)
1- Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
2- Drafting the work or revising it critically for important intellectual content; AND
3- Final approval of the version to be published; AND
4- Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
We request all authors and reviewers to inform us about any kinds of “Conflict of Interest” (such as financial, personal, political, or academic) that would potentially affect their judgment. Authors are preferably asked to fill the uniform disclosure form available through:
(http://www.icmje.org/coi_disclosure.pdf)
Authors are not allowed to utilize verbatim text of previously published papers or manuscripts submitted elsewhere. COPE’s flowcharts and guidelines are approached in cases in which plagiarism is detected.
It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered.
All authors are strongly recommended to check their manuscripts content before its submission to the journal for publication. The Authors may use trustable valid "Plagiarism Checking softwares" to make sure that their manuscripts are Plagiarism free.
To ensure originality, all submitted manuscripts undergo rigorous plagiarism checks using the iThenticate software. Manuscripts showing significant textual overlap or inadequate citation practices may be returned to authors for revision or directly rejected, depending on the extent of the issue.
• Policy on Misconduct
The journal adheres to strict ethical guidelines regarding misconduct. Misconduct includes but is not limited to data fabrication, data falsification, plagiarism, duplicate publication, authorship fraud, and unethical experimentation. All allegations of misconduct are taken seriously and investigated thoroughly. Confirmed misconduct may result in manuscript rejection, retraction of published articles, notification of the author’s institution, and banning from future submissions.
• Intellectual Property
The journal respects and protects intellectual property rights. Authors must ensure that all figures, tables, and previously published materials included in their manuscripts are properly cited and permission for reproduction has been obtained where necessary. Violations of intellectual property rights will be treated as misconduct and managed accordingly.
• Data Fabrication/Falsification
Falsification is the practice of omitting or altering research materials, data, or processes so that the results of the research are no longer accurately reflected. Fabrication is the practice of inventing data or results and reporting them in the research. Both of these misconducts are fraudulent and seriously alter the integrity of research. Therefore, articles must be written based on original data and use of falsified or fabricated data is strongly prohibited. COPE’s flowcharts and guidelines are approached in cases in which any of these two misconducts is detected. Researchers who perform randomized controlled or clinical trials (RCTs) are advised to keep their original data at hand. The Journal keeps the right to ask for raw data even after publication.
• Image Manipulation
The CBJ encourages authors to send their original images. All digital images in manuscripts accepted for publication will be checked for inappropriate manipulation. No specific feature within an image may be enhanced, obscured, moved, removed, or introduced. Adjustments of brightness, contrast, or color balance are acceptable as long as they are applied to the entire image and do not misrepresent any information present in the original, including the background. The editors will request the original data from the authors to compare the manipulated figures in cases suspected of inappropriate manipulation.
If a manuscript contains any previously published image or text, it is the responsibility of the author to obtain authorization from copyright holders. The author is required to obtain and submit the written original permission letters for all copyrighted material used in his/her manuscripts.
All content published in this journal, including articles, editorials, and reviews, remains protected under copyright law. Upon acceptance of a manuscript, authors transfer the copyright to the journal, granting it the exclusive right to publish, distribute, and archive the article. However, authors retain certain rights, including the ability to reuse portions of their work in future research, presentations, or teaching activities, provided proper acknowledgment to the journal is given.
• Licensing
This journal publishes under the Creative Commons Attribution 4.0 International License (CC BY 4.0). Under this license, authors and readers are free to:
The only requirement is appropriate credit to the original authors and the journal, with a link to the license and a clear indication if changes were made. This approach maximizes the visibility, dissemination, and impact of published research.
• Journal Policy on Artificial Intelligence (AI) Usage
This journal maintains a rigorous ethical standard regarding AI-generated content. Manuscripts that utilize AI tools must clearly disclose the nature, scope, and purpose of AI assistance in the 'Methods' and/or 'Acknowledgments' sections. Specifically:
Authors and reviewers are encouraged to follow best practices as recommended by international bodies such as the Committee on Publication Ethics (COPE) and ensure full transparency in manuscript preparation and submission.
The CBJ uses the COPE flowchart for retraction of a published article to determine whether a published article should be retracted.
The CBJ responds promptly to complaints and ensures there is a way for dissatisfied complainants to take complaints further by sending an email to editor-in-chief of the journal. We follow the COPE's guidelines and flowcharts for handling complaints against the journal, its staff, editorial board or publisher.
Cardiovascular Biomedicine Journal works with some organizations such as Magiran, Google Scholar, E-prints and own server of Shahid Sadoughi University of Medical Sciences for maintaining our own digital archive. This makes it possible the permanent availability and preservation of scholarly research and to ensure accessibility by converting and upgrading digital file formats to comply with new technology standards.